1 December 2017 - 30 November 2018
Principal institution: Genentech, Inc.
Subject/journal group: All
The table to the right includes counts of all research outputs for Department of Translational Oncology, Genentech, Inc. published between 1 December 2017 - 30 November 2018 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Outputs by subject (FC)
Top articles by Altmetric score in current window
CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.
Proceedings of the National Academy of Sciences of the United States of America
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.